FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2039761330> ?p ?o ?g. }

• W2039761330 endingPage "1294" @default.
• W2039761330 startingPage "1287" @default.
• W2039761330 abstract "Background New oral anticoagulants may simplify long-term therapy by eliminating the need for laboratory monitoring. Edoxaban is an oral, direct inhibitor of factor Xa that is given in a fixed dose once daily. Objective and methods The Hokusai-VTE study is a randomized, double-blind trial to evaluate whether initial low molecular weight heparin (LMWH) followed by edoxaban (60 mg once daily) is non-inferior to LMWH followed by warfarin (International Normalized Ratio of 2.0–3.0) for the prevention of recurrent thromboembolism in patients with acute symptomatic venous thromboembolism (VTE). The primary efficacy outcome is symptomatic recurrent VTE during the 12-month study period. The principal safety outcome is clinically relevant bleeding (major or non-major) occurring during or within 3 days of stopping study treatment. A clinical events committee adjudicates all suspected outcome events. A unique study design feature is the flexible treatment duration of between 3 and 12 months to simulate usual clinical practice, and enabled by: (i) double-blinding to minimize bias that could occur if knowledge of the patient's treatment influenced the duration of therapy; and (ii) follow-up for 12 months of all patients and inclusion in the primary efficacy analysis, regardless of the duration of therapy received. A second innovative design feature is the strategy for achieving an appropriate time in therapeutic range in the warfarin group, with central tracking for each participating center and feedback to the investigators. Conclusion The standard methods combined with innovative design features should achieve study results that are both scientifically valid and relevant to clinical practice." @default.
• W2039761330 created "2016-06-24" @default.
• W2039761330 creator A5012151994 @default.
• W2039761330 creator A5016834175 @default.
• W2039761330 creator A5039204383 @default.
• W2039761330 creator A5042290277 @default.
• W2039761330 creator A5049607454 @default.
• W2039761330 creator A5059802381 @default.
• W2039761330 creator A5078033695 @default.
• W2039761330 creator A5088320381 @default.
• W2039761330 date "2013-07-01" @default.
• W2039761330 modified "2023-10-09" @default.
• W2039761330 title "Edoxaban for the long‐term treatment of venous thromboembolism: rationale and design of the Hokusai‐venous thromboembolism study – methodological implications for clinical trials" @default.
• W2039761330 cites W1528007237 @default.
• W2039761330 cites W1586488555 @default.
• W2039761330 cites W1866866972 @default.
• W2039761330 cites W1986579965 @default.
• W2039761330 cites W1997104987 @default.
• W2039761330 cites W1997637512 @default.
• W2039761330 cites W1998354077 @default.
• W2039761330 cites W2027735039 @default.
• W2039761330 cites W2042797600 @default.
• W2039761330 cites W2063464618 @default.
• W2039761330 cites W2068586141 @default.
• W2039761330 cites W2075917870 @default.
• W2039761330 cites W2103053426 @default.
• W2039761330 cites W2112378432 @default.
• W2039761330 cites W2115787552 @default.
• W2039761330 cites W2118092611 @default.
• W2039761330 cites W2130199362 @default.
• W2039761330 cites W2131099415 @default.
• W2039761330 cites W2132370419 @default.
• W2039761330 cites W2159553511 @default.
• W2039761330 cites W2163785468 @default.
• W2039761330 cites W2170493914 @default.
• W2039761330 cites W2189476799 @default.
• W2039761330 cites W2314358062 @default.
• W2039761330 cites W2522675690 @default.
• W2039761330 cites W3093693179 @default.
• W2039761330 doi "https://doi.org/10.1111/jth.12230" @default.
• W2039761330 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23574579" @default.
• W2039761330 hasPublicationYear "2013" @default.
• W2039761330 type Work @default.
• W2039761330 sameAs 2039761330 @default.
• W2039761330 citedByCount "73" @default.
• W2039761330 countsByYear W20397613302013 @default.
• W2039761330 countsByYear W20397613302014 @default.
• W2039761330 countsByYear W20397613302015 @default.
• W2039761330 countsByYear W20397613302016 @default.
• W2039761330 countsByYear W20397613302017 @default.
• W2039761330 countsByYear W20397613302018 @default.
• W2039761330 countsByYear W20397613302019 @default.
• W2039761330 countsByYear W20397613302020 @default.
• W2039761330 countsByYear W20397613302021 @default.
• W2039761330 countsByYear W20397613302022 @default.
• W2039761330 countsByYear W20397613302023 @default.
• W2039761330 crossrefType "journal-article" @default.
• W2039761330 hasAuthorship W2039761330A5012151994 @default.
• W2039761330 hasAuthorship W2039761330A5016834175 @default.
• W2039761330 hasAuthorship W2039761330A5039204383 @default.
• W2039761330 hasAuthorship W2039761330A5042290277 @default.
• W2039761330 hasAuthorship W2039761330A5049607454 @default.
• W2039761330 hasAuthorship W2039761330A5059802381 @default.
• W2039761330 hasAuthorship W2039761330A5078033695 @default.
• W2039761330 hasAuthorship W2039761330A5088320381 @default.
• W2039761330 hasBestOaLocation W20397613301 @default.
• W2039761330 hasConcept C126322002 @default.
• W2039761330 hasConcept C141071460 @default.
• W2039761330 hasConcept C148482608 @default.
• W2039761330 hasConcept C168563851 @default.
• W2039761330 hasConcept C177713679 @default.
• W2039761330 hasConcept C2776301958 @default.
• W2039761330 hasConcept C2778661090 @default.
• W2039761330 hasConcept C2778810321 @default.
• W2039761330 hasConcept C2779161974 @default.
• W2039761330 hasConcept C2779630707 @default.
• W2039761330 hasConcept C2780290652 @default.
• W2039761330 hasConcept C2780868729 @default.
• W2039761330 hasConcept C2991741193 @default.
• W2039761330 hasConcept C3017811039 @default.
• W2039761330 hasConcept C535046627 @default.
• W2039761330 hasConcept C71924100 @default.
• W2039761330 hasConceptScore W2039761330C126322002 @default.
• W2039761330 hasConceptScore W2039761330C141071460 @default.
• W2039761330 hasConceptScore W2039761330C148482608 @default.
• W2039761330 hasConceptScore W2039761330C168563851 @default.
• W2039761330 hasConceptScore W2039761330C177713679 @default.
• W2039761330 hasConceptScore W2039761330C2776301958 @default.
• W2039761330 hasConceptScore W2039761330C2778661090 @default.
• W2039761330 hasConceptScore W2039761330C2778810321 @default.
• W2039761330 hasConceptScore W2039761330C2779161974 @default.
• W2039761330 hasConceptScore W2039761330C2779630707 @default.
• W2039761330 hasConceptScore W2039761330C2780290652 @default.
• W2039761330 hasConceptScore W2039761330C2780868729 @default.
• W2039761330 hasConceptScore W2039761330C2991741193 @default.
• W2039761330 hasConceptScore W2039761330C3017811039 @default.
• W2039761330 hasConceptScore W2039761330C535046627 @default.
• W2039761330 hasConceptScore W2039761330C71924100 @default.

• next